PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...

Raising and narrowing 2024 guidance ranges: Adjusted EBITDA of $750 to $780 million and Adjusted Free Cash Flow of $265 to $285 million. Reaffirming 2025 guidance ranges: Adjusted EBITDA of $925 to $1 ...

PTC Therapeutics (PTCT) announced that the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever ...

Over 1,000 companies, including Muthoot Finance and Grasim, will release Q2FY24-25 results today. The Niva Bupa <a ...

The SmartFlow Neuro Cannula is intended for intraputaminal administration of PTC Therapeutics' gene therapy KEBILIDI ™ ...

Q3 marks the largest bookings in Ondas' history$14.4 million in purchase orders were from a major military customer for the Iron Drone Raider and Optimus System autonomous drone platformsIron Drone Ra ...

Renesas Electronics Corporation, a supplier of advanced semiconductor solutions, today announced the world's first “8-in-1” ...

Joseph Schwartz, an analyst from Leerink Partners, reiterated the Hold rating on PTC Therapeutics (PTCT – Research Report). The ...

Personal Finance Society (PFS) chair Christine Elliott has admitted the ongoing dispute between the organisation and the Chartered Insurance Institute (CII) is professionally embarrassing but assured ...

PFS members took the CII to task on Tuesday (11 November) for flooding the board just before Christmas 2022, for the ...

LONDON, GREATER LONDON, UNITED KINGDOM, November 12, 2024 /EINPresswire / -- The Business Research Company 's Early Year-End Sale! Get up to 30% off detailed market research reports-limited time only!